Search Results - Bart Neyns

Refine Results
  1. 1

    Long-term disease control of Langerhans cell histiocytosis using combined BRAF and MEK inhibition by Gil Awada, Teofila Seremet, Karel Fostier, Hendrik Everaert, Bart Neyns

    Published in Blood Advances (2018-08-01)
    Get full text
    Article


  2. 2

    Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome by Sim Vermeulen, Gil Awada, Marleen Keyaerts, Bart Neyns, Hendrik Everaert

    Published in Current Oncology (2021-04-01)
    Get full text
    Article


  3. 3

    Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report by Ine Lambert, Giuseppe Fasolino, Gil Awada, Robert Kuijpers, Marcel ten Tusscher, Bart Neyns

    Published in BMC Ophthalmology (2021-06-01)
    Get full text
    Article


  4. 4

    Successful treatment of MAP2K1 mutant stage IV-M1d melanoma with trametinib plus low-dose dabrafenib: a case report by Iris Dirven, Evan Calliauw, Gil Awada, Manon Vounckx, Jolien I. Kessels, Bart Neyns

    Published in Frontiers in Medicine (2024-09-01)
    Get full text
    Article


  5. 5

    A Solitary Melanoma Metastasis Confined to the Submandibular Gland by Senne Gorris, Celia Perdaens, Veerle Delvaux, Vincent Vander Poorten, Bart Neyns, Ilan Baron

    Published in Case Reports in Oncology (2021-06-01)
    Get full text
    Article


  6. 6

    A Case Report of Long-Term Survival following Hepatic Arterial Infusion of L-Folinic Acid Modulated 5-Fluorouracil Combined with Intravenous Irinotecan and Cetuximab Followed by He... by Kobe Van Bael, Yanina Jansen, Teofila Seremet, Benedikt Engels, Georges Delvaux, Bart Neyns

    Published in Case Reports in Oncological Medicine (2015-01-01)
    Get full text
    Article


  7. 7

    TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma by Bart Neyns, Kris Thielemans, Sofie Wilgenhof, Jurgen Corthals, Brenda De Keersmaecker, Sofie Claerhout, Javier Carrasco, Isabelle Bar

    Published in Journal for ImmunoTherapy of Cancer (2020-05-01)
    Get full text
    Article


  8. 8

    Intratumoral Combinatorial Administration of CD1c (BDCA-1)<sup>+</sup> Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Pa... by Julia Katharina Schwarze, Gil Awada, Louise Cras, Jens Tijtgat, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, Bart Neyns

    Published in Vaccines (2020-11-01)
    Get full text
    Article


  9. 9

    Oncolytic HSV-1 expressing FLT3L kills melanoma, glioblastoma, and pancreatic cancer cells in vitro and induces immunogenic cell death by Sandra Tuyaerts, Xenia Geeraerts, Alberto Reale, Latoya Stevens, Giada Bertazzon, Jack Brons, Toon Janssen, Ivan Van Riet, Arianna Calistri, Bart Neyns

    Published in Molecular Therapy: Oncology (2025-09-01)
    Get full text
    Article


  10. 10

    Successful Treatment with Dabrafenib/Trametinib of a Malignantly Transformed and Metastasized BRAF V600E Mutant Pleiomorphic Xanthoastrocytoma: A Case Report and Review of the Lite... by Elle Vermeulen, An-Sofie Vander Mijnsbrugge, Stefanie Brock, Freya Vaeyens, Iris Dirven, Abdulhamid Ciçek, William Marcelis, Samuel Klein, Michaël Bruneau, Bart Neyns, Johnny Duerinck

    Published in Case Reports in Oncology (2024-01-01)
    Get full text
    Article


  11. 11

    Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory adva... by Bart Neyns, Angela Vasaturo, Julia Katharina Schwarze, Gil Awada, Ramses Forsyth, Jens Tijtgat, Louise Cras, Christopher Bagnall, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet

    Published in Journal for ImmunoTherapy of Cancer (2022-09-01)
    Get full text
    Article


  12. 12

    Pituitary carcinoma - case series and review of the literature by Stephanie Du Four, Stephanie Du Four, Jorn Van Der Veken, Johnny Duerinck, Elle Vermeulen, Corina E. Andreescu, Michael Bruneau, Bart Neyns, Van Velthoven, Brigitte Velkeniers

    Published in Frontiers in Endocrinology (2022-09-01)
    Get full text
    Article


  13. 13

    Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab by Anne Rogiers, Christophe Leys, Justine Lauwyck, Adrian Schembri, Gil Awada, Julia Katharina Schwarze, Jennifer De Cremer, Peter Theuns, Paul Maruff, Mark De Ridder, Jan L. Bernheim, Bart Neyns

    Published in Journal of Immunology Research (2020-01-01)
    Get full text
    Article


  14. 14

    Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma Patients by Stephanie Du Four, Angela Hong, Matthew Chan, Michail Charakidis, Johnny Duerinck, Sofie Wilgenhof, Wei Wang, Linda Feng, Alex Michotte, Meena Okera, Brindha Shivalingam, Gerald Fogarty, Richard Kefford, Bart Neyns

    Published in Case Reports in Oncological Medicine (2014-01-01)
    Get full text
    Article


  15. 15

    Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous... by Bart Neyns, Julia Katharina Schwarze, Karen Willard-Gallo, Ramses Forsyth, Jens Tijtgat, Sandra Tuyaerts, Ivan Van Riet, Steven Raeymaeckers, Xenia Geeraerts, Latoya Stevens, Manon Vounckx, Iris Dirven, Anais Boisson

    Published in Journal for ImmunoTherapy of Cancer (2024-01-01)
    Get full text
    Article


  16. 16

    Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity by Bart Neyns, Sandra Tuyaerts, Ivan Van Riet, Karine Breckpot, Fien Meeus, Cyprine Neba Funeh, Robin Maximilian Awad, Katty Zeven, Dorien Autaers, Ann De Becker, Cleo Goyvaerts, Nick Devoogdt, Yannick De Vlaeminck

    Published in Journal for ImmunoTherapy of Cancer (2024-11-01)
    Get full text
    Article


  17. 17

    Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx) by Bart Neyns, Julia Katharina Schwarze, Gil Awada, Laila Ben Salama, Jennifer De Cremer, Lydia Fischbuch, Laura Seynaeve, Stephanie Du Four, Anne-Marie Vanbinst, Alex Michotte, Hendrik Everaert, Anne Rogiers, Peter Theuns, Johnny Duerinck

    Published in Journal for ImmunoTherapy of Cancer (2020-10-01)
    Get full text
    Article


  18. 18

    The clinical application of cancer immunotherapy based on naturally circulating dendritic cells by Kalijn F. Bol, Gerty Schreibelt, Katrin Rabold, Stefanie K. Wculek, Julia Katharina Schwarze, Andrzej Dzionek, Alvaro Teijeira, Lana E. Kandalaft, Pedro Romero, George Coukos, Bart Neyns, David Sancho, Ignacio Melero, I. Jolanda M. de Vries

    Published in Journal for ImmunoTherapy of Cancer (2019-04-01)
    Get full text
    Article


  19. 19

    694 A randomized phase II clinical trial of SBRT and pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c(BDCA-1)+/CD141(BDCA-3)+ myeloid dendritic cells in sol... by Bart Neyns, Bart Ilsen, Jens Tijtgat, Frederik Vandenbroucke, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, Xenia Geeraerts, Latoya Stevens, Manon Vounckx, Iris Dirven, Steven Raemaeckers, Selma Ben Mustapha, Jens Van Loon, Lore Decoster, Mark De Ridder

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  20. 20

    Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial by Mark Kockx, Bart Neyns, Julia Katharina Schwarze, Gil Awada, Laura Seynaeve, Anne-Marie Vanbinst, Alex Michotte, Hendrik Everaert, Johnny Duerinck, Ramses Forsyth, Jens Tijtgat, Freya Vaeyens, Cleo Bertels, Wietse Geens, Samuel Klein, Louise Cras, Nicky D’Haene, Ben Caljon, Isabelle Salmon, Michaël Bruneau, Sonia Van Dooren

    Published in Journal for ImmunoTherapy of Cancer (2021-06-01)
    Get full text
    Article


Search Tools: